Boca Raton, FL (PRWEB) August 07, 2014
Wimbledon Health Partners (WHP), a leading on-site diagnostic testing company, appointed Stewart Whyte as Chief Operating Officer in yet another sign of the company's increasing market leadership. Whyte, a healthcare industry leader, has been charged with managing the growing organizations operations. With a successful track record in major to early stage companies expanding over 35 years in the healthcare industry, Mr. Whyte will apply his leadership expertise with some of the most innovative healthcare companies in the world to his newly appointed position with Wimbledon Health Partners.
Hiring Mr. Whyte is further evidence of Wimbledon Health Partners enduring commitment to enhance the strength of its executive team. Whyte brings with him major achievements from his experience with Liberty Life, Discovery Holdings and Destiny Health. As Chief Executive of Operations, Charter Member and Senior Executive Director of Operations with Destiny and Discovery Health, he succeeded in migrating the back office functionality of Destiny Health, in Chicago, IL to its parent company, Discovery Holdings in South Africa. The same model was utilized in the joint venture between Discovery Holdings and Prudential Health Insurance, UK. Additionally, Mr. Whyte chartered the operational aspects of Discovery Health, collecting contributions of $200 million per month and a market cap worth $2 billion.
Mr. Whyte will focus his efforts on further developing Wimbledon Health Partners exceedingly well-run operations. He will draw on his extensive knowledge of claims processing systems, contribution management, medical management services, and leadership in implementing a model department to further the forecasted growth.
“I am truly excited about joining Wimbledon Health Partners, as the potential for growth both inside the United States and internationally is seemingly limitless. Although I have been in healthcare for over 35 years and have been involved with both small and large ventures, the potential I see at Wimbledon has me very excited. Wimbledon has built a solid foundation and with my extensive knowledge and contacts in the industry we are well on the way to building a billion dollar company,” stated Whyte.
About Wimbledon Health Partners:
Wimbledon Health Partners is a national on-site diagnostic testing organization with capabilities for diagnosing circulatory conditions that can be detected through the use of cardiovascular ultrasound and echocardiogram. Additional capabilities include nerve conduction velocity testing (NCV), which is utilized to support the diagnosis of nerve involvement of circulatory disease, and help assess cardiovascular risk. Wimbledon Health Partners provides an innovative cooperative marketing and practice-enhancement program to physicians with the educational, compliance, and marketing tools necessary to deliver quality state-of-the-art in-office testing procedures. For more information go to http://www.dxtesting.com or call 855-200-8262.